Filter
371
Filtered Results: 371
Text search:
M.
Cheng
Featured
Recommendations
46
New Publications
53
Language
Document type
No document type
150
Guidelines
102
Studies & Reports
82
Manuals
13
Fact sheets
10
Strategic & Response Plan
6
Training Material
3
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
Global
17
Russia
14
India
13
Zimbabwe
12
Brazil
10
Germany
8
Rwanda
8
Congo, Democratic Republic of
7
Kenya
7
Malawi
7
Western and Central Europe
7
Spain
7
Ethiopia
6
Tanzania
6
China
6
South Africa
6
Middle East and North Africa
6
Zambia
5
Nigeria
4
Ghana
4
Syria
4
Mozambique
4
Ukraine
4
Latin America and the Carribbean
4
Asia
4
Africa
4
Guinea
3
Burkina Faso
3
Sierra Leone
3
Liberia
3
Senegal
3
Guinea-Bissau
3
Cameroon
3
Uganda
3
Nepal
3
Indonesia
3
Ecuador
3
Bolivia
3
Angola
3
Lesotho
3
Chile
3
Yemen
3
Eastern Europe and Central Asia
3
Vietnam
3
Côte d’Ivoire / Ivory Coast
2
USA
2
Haiti
2
Philippines
2
Cambodia
2
Argentina
2
Eswatini/ Swaziland
2
Burundi
2
Paraguay
2
Eastern Europe
2
France
2
Mali
1
Niger
1
South Sudan
1
Afghanistan
1
Turkey
1
Malaysia
1
Bangladesh
1
Sudan
1
Peru
1
Austria
1
Switzerland
1
Colombia
1
Madagascar
1
Venezuela
1
Laos
1
Canada
1
Kyrgyzstan
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
133
Clinical Guidelines
37
Public Health
14
Women & Child Health
12
Key Resources
6
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
COVID-19
113
Mental Health
34
HIV
30
Planetary Health
20
TB
12
NCDs
11
NTDs
10
Disability
8
Global Health Education
7
AMR
7
Health Financing Toolbox
6
Natural Hazards
5
Caregiver
5
Rapid Response
4
Refugee
4
Pharmacy
3
Ebola
2
Polio
2
Zika
2
Social Ethics
1
Systematic Review Summary 4
Moving avidence into action
This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat...
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
as of 12:00 AM, 17 September 2018 - 6:00 AM, 17 September 2018
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distingu...
PLoS Medicine Vol. 6 no. 10 (2009) e1000165
NATIONAL HIV/AIDS/STI/TB COUNCIL DEVOLUTION PLAN
Public Health Factsheet
Accessed: 29.09.2019
This document was designed to inform educators, amongst others, about enhancing the pre-service curriculum with mental health Gap Action Programme Intervention Guide (mhGAP-IG) materials, which can provide future professionals with the theoretical and clinical knowledge they need to provide mental h...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the further implementation of the Convention.
GBO-5 pro...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
It explains the importance of faecal sludge management in urban areas in which many people rely on on-site and decentralized sanitation facilities and emphasizes the place of treatment in the overall sanitation service chain. It defines terms used throughout the book, explains why faecal sludge and ...
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...
This report provides an overview of air pollution levels and associated health impacts in cities around the world. Since urban areas are often hotspots for poor air quality, city-level data can help to inform targeted efforts to curb urban air pollution and improve public health. This report draws o...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
